Logo do repositório
 
Publicação

Erylusamides: Novel Atypical Glycolipids from Erylus cf. deficiens

dc.contributor.authorGaspar, Helena
dc.contributor.authorCutignano, Adele
dc.contributor.authorGrauso, Laura
dc.contributor.authorNeng, Nuno
dc.contributor.authorCachatra, Vasco
dc.contributor.authorFontana, Angelo
dc.contributor.authorXavier, Joana
dc.contributor.authorCerejo, Marta
dc.contributor.authorVieira, Helena
dc.contributor.authorSantos, Susana
dc.date.accessioned2020-01-19T21:25:55Z
dc.date.available2020-01-19T21:25:55Z
dc.date.issued2016
dc.description.abstractAmong marine organisms, sponges are the richest sources of pharmacologically-active compounds. Stemming from a previous lead discovery program that gathered a comprehensive library of organic extracts of marine sponges from the off-shore region of Portugal, crude extracts of Erylus cf. deficiens collected in the Gorringe Bank (Atlantic Ocean) were tested in the innovative high throughput screening (HTS) assay for inhibitors of indoleamine 2,3-dioxygenase (IDO) and showed activity. Bioassay guided fractionation of the dichloromethane extract led to the isolation of four new glycolipids, named erylusamide A-D. The structures of the isolated compounds were established by 1D and 2D nuclear magnetic resonance (NMR) spectroscopy, high-resolution electrospray ionization mass spectrometry (HR-ESI-MS) and chemical derivatization. The metabolites shared a pentasaccharide moiety constituted by unusual highly acetylated ᴅ-glucose moieties as well as ᴅ-xylose and ᴅ-galactose. The aglycones were unprecedented long chain dihydroxyketo amides. Erylusamides A, B and D differ in the length of the hydrocarbon chain, while erylusamide C is a structural isomer of erylusamide B.pt_PT
dc.description.versioninfo:eu-repo/semantics/publishedVersionpt_PT
dc.identifier.doi10.3390/md14100179pt_PT
dc.identifier.issn1660-3397
dc.identifier.urihttp://hdl.handle.net/10451/41250
dc.language.isoengpt_PT
dc.publisherMDPIpt_PT
dc.relation.publisherversionhttps://www.mdpi.com/1660-3397/14/10/179pt_PT
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/pt_PT
dc.subjectEryluspt_PT
dc.subjectindoleamine 2,3 dioxygenasept_PT
dc.subjectglycolipidspt_PT
dc.subjectmarine natural productspt_PT
dc.subjectspongespt_PT
dc.subjectanti-cancerpt_PT
dc.subjecterylusamidespt_PT
dc.titleErylusamides: Novel Atypical Glycolipids from Erylus cf. deficienspt_PT
dc.typejournal article
dspace.entity.typePublication
oaire.citation.issue10pt_PT
oaire.citation.startPage179pt_PT
oaire.citation.titleMarine Drugspt_PT
oaire.citation.volume14pt_PT
person.familyNameGaspar
person.givenNameHelena
person.identifier1333426
person.identifier.ciencia-id761C-044C-995B
person.identifier.orcid0000-0002-1613-7023
person.identifier.ridE-6798-2012
person.identifier.scopus-author-id7003891380
rcaap.rightsopenAccesspt_PT
rcaap.typearticlept_PT
relation.isAuthorOfPublication95eee1cb-9280-463b-9774-fc4153681257
relation.isAuthorOfPublication.latestForDiscovery95eee1cb-9280-463b-9774-fc4153681257

Ficheiros

Principais
A mostrar 1 - 1 de 1
A carregar...
Miniatura
Nome:
MARE_ULisboa_MarineDrugs_14(10)_2016_179.pdf
Tamanho:
2.57 MB
Formato:
Adobe Portable Document Format
Licença
A mostrar 1 - 1 de 1
Miniatura indisponível
Nome:
license.txt
Tamanho:
1.2 KB
Formato:
Item-specific license agreed upon to submission
Descrição: